Allan Coukell is Pew’s senior director for health programs. He oversees initiatives related to drug and medical device innovation and safety, medical conflicts-of-interest, the pharmaceutical supply chain, pharmacy compounding, antibiotic resistance, prescription drug abuse, FDA, specialty drugs, food safety, school nutrition, as well as other efforts related to health costs and care delivery.
Prior to joining Pew, he practiced as a clinical pharmacist in oncology at the London Health Sciences Center and Ontario Regional Cancer Center, served as a senior medical writer and editor with the medical journal publisher Adis International, and covered health and science as a reporter and producer for WBUR (NPR) in Boston and Radio New Zealand. He is Vice Chair of the Medical Device Innovation Consortium and a board member of the Reagan Udall Foundation for the FDA. He served previously as consumer representative on the FDA’s Cardiovascular and Renal Drugs Advisory Committee.
The Pew Charitable Trusts is pleased to offer comments on the implementation of provisions in the Comprehensive Addiction and Recovery Act (CARA) intended to prevent prescription drug misuse in Medicare. Pew is an independent, nonpartisan research and policy organization dedicated to serving the public. Read More
Last week, Vivek Murthy, the U.S. surgeon general, released Facing Addiction in America, the first report from the nation’s top physician to examine the effects of drug and alcohol misuse in the United States. The landmark report takes a comprehensive look at this urgent public health issue and calls for a holistic, evidence-based approach to prevent and treat substance use disorders.... Read More
Opioid overdoses cause one death every 20 minutes. Medication-assisted treatment (MAT)—a combination of psychosocial therapy and U.S. Food and Drug Administration-approved medication—is the most effective intervention to treat opioid use disorder (OUD) and is more effective than either behavioral interventions or medication alone. MAT significantly reduces illicit opioid use compared... Read More